US Patent 9845291 Estrogen receptor modulators and uses thereof
Patent 9845291 was granted and assigned to Genentech on December, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 30 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+99 characters)
Article
Patent abstract
Described herein are compounds that are estrogen receptor modulators of Formula (I):
Edits on 2 Aug, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09845291 Estrogen receptor modulators and uses thereof US Patent 9845291 Estrogen receptor modulators and uses thereof
Infobox
Patent Number
0984529100
Patent Number
984529100
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
098452910
Date of Patent
December 19, 2017
0Patent Application Number
149723330
Date Filed
December 17, 2015
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
098452910
Date of Patent
December 19, 2017
0Patent Application Number
149723330
Date Filed
December 17, 2015
0Patent Primary Examiner
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09845291 Estrogen receptor modulators and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09845291
Date of patent
December 19, 2017
Patent application number
14972333
Date Filed
December 17, 2015
Patent primary examiner
Find more entities like US Patent 9845291 Estrogen receptor modulators and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.